Minerva Neurosciences Stock (NASDAQ: NERV) stock price, news, charts, stock research, profile.
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: NKGen Biotech (NASDAQ:NKGN), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN), Can Fite Biofarma (AMEX:CANF) and Nanoviricides (AMEX:NNVC).
Minerva Neurosciences has a consensus price target of $5.00.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.16 last updated November 19, 2024 at 5:41 PM EST.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.